For Sales
From
Description
The bio-pharma service business provides manufacturing and development services for pharmaceutical intermediates and active pharmaceutical ingredients (APIs) to pharmaceutical companies. It is a field in which the Ajinomoto Group can utilize the fermentation and synthesis technologies it has honed through the manufacture of amino acids and nucleotides. Based on these technologies, the Group processed amino acids to add value as pharmaceutical intermediates, and we started this business in the 1980s with the development of a contract business for amino acid derivatives. Later in the 1980s, the Group acquired S.A. OmniChem N.V. of Belgium and we have since been providing manufacturing services for pharmaceutical intermediates, APIs and high-potency APIs (HPAPIs), mainly for customers in the United States and Europe.